ALNY
Alnylam Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
2.46 / 10
Underperform
Fundamental assessment: 2.5/10 points to challenging condition. Positive attributes: Days sales outstanding and Cost of sales ratio (%), although drawbacks are visible in Income tax / Total profit (%) and PB-ROE. Concluding perspective: prudent.
Analysis Checks(6/10)
Revenue-MV
Value-1.31
Score1/3
Weight12.37%
1M Return4.20%
Value-1.31
Score1/3
Weight12.37%
1M Return4.20%
Profit-MV
Value-2.04
Score2/3
Weight27.95%
1M Return9.19%
Value-2.04
Score2/3
Weight27.95%
1M Return9.19%
Income tax / Total profit (%)
Value21.41
Score1/3
Weight0.03%
1M Return0.01%
Value21.41
Score1/3
Weight0.03%
1M Return0.01%
Operating revenue (YoY growth rate %)
Value58.11
Score2/3
Weight1.29%
1M Return0.55%
Value58.11
Score2/3
Weight1.29%
1M Return0.55%
Asset-MV
Value-0.50
Score0/3
Weight19.71%
1M Return7.07%
Value-0.50
Score0/3
Weight19.71%
1M Return7.07%
Days sales outstanding
Value70.68
Score3/3
Weight3.12%
1M Return1.30%
Value70.68
Score3/3
Weight3.12%
1M Return1.30%
PB-ROE
Value11.18
Score0/3
Weight6.15%
1M Return2.29%
Value11.18
Score0/3
Weight6.15%
1M Return2.29%
Interest coverage ratio (EBIT / Interest expense) (%)
Value5.21
Score2/3
Weight-1.50%
1M Return-0.66%
Value5.21
Score2/3
Weight-1.50%
1M Return-0.66%
Cost of sales ratio (%)
Value15.83
Score3/3
Weight1.82%
1M Return0.72%
Value15.83
Score3/3
Weight1.82%
1M Return0.72%
Cash-MV
Value-1.13
Score3/3
Weight29.05%
1M Return9.70%
Value-1.13
Score3/3
Weight29.05%
1M Return9.70%
Revenue-MV
Value-1.31
Score1/3
Weight12.37%
1M Return4.20%
Value-1.31
Score1/3
Weight12.37%
1M Return4.20%
Days sales outstanding
Value70.68
Score3/3
Weight3.12%
1M Return1.30%
Value70.68
Score3/3
Weight3.12%
1M Return1.30%
Profit-MV
Value-2.04
Score2/3
Weight27.95%
1M Return9.19%
Value-2.04
Score2/3
Weight27.95%
1M Return9.19%
PB-ROE
Value11.18
Score0/3
Weight6.15%
1M Return2.29%
Value11.18
Score0/3
Weight6.15%
1M Return2.29%
Income tax / Total profit (%)
Value21.41
Score1/3
Weight0.03%
1M Return0.01%
Value21.41
Score1/3
Weight0.03%
1M Return0.01%
Interest coverage ratio (EBIT / Interest expense) (%)
Value5.21
Score2/3
Weight-1.50%
1M Return-0.66%
Value5.21
Score2/3
Weight-1.50%
1M Return-0.66%
Operating revenue (YoY growth rate %)
Value58.11
Score2/3
Weight1.29%
1M Return0.55%
Value58.11
Score2/3
Weight1.29%
1M Return0.55%
Cost of sales ratio (%)
Value15.83
Score3/3
Weight1.82%
1M Return0.72%
Value15.83
Score3/3
Weight1.82%
1M Return0.72%
Asset-MV
Value-0.50
Score0/3
Weight19.71%
1M Return7.07%
Value-0.50
Score0/3
Weight19.71%
1M Return7.07%
Cash-MV
Value-1.13
Score3/3
Weight29.05%
1M Return9.70%
Value-1.13
Score3/3
Weight29.05%
1M Return9.70%
Is ALNY fundamentally strong?
- ALNY scores 2.46/10 on fundamentals and holds a Premium valuation at present. Backed by its 84.61% ROE, 1.36% net margin, 995.17 P/E ratio, 185.36 P/B ratio, and 112.60% earnings growth, these metrics solidify its Underperform investment rating.
